Cargando…
Melatonin as a therapy in cardiac ischemia-reperfusion injury: Potential mechanisms by which MT2 activation mediates cardioprotection
INTRODUCTION: Previous studies reported the beneficial effects of pretreatment with melatonin on the heart during cardiac ischemia/reperfusion (I/R) injury. However, the effects of melatonin given after cardiac ischemia, as well as its comparative temporal effects are unknown. These include pretreat...
Autores principales: | Singhanat, Kodchanan, Apaijai, Nattayaporn, Jaiwongkam, Thidarat, Kerdphoo, Sasiwan, Chattipakorn, Siriporn C., Chattipakorn, Nipon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020169/ https://www.ncbi.nlm.nih.gov/pubmed/33842003 http://dx.doi.org/10.1016/j.jare.2020.09.007 |
Ejemplares similares
-
Acute dapagliflozin administration exerts cardioprotective effects in rats with cardiac ischemia/reperfusion injury
por: Lahnwong, Sarayut, et al.
Publicado: (2020) -
Erythropoietin administration exerted neuroprotective effects against cardiac ischemia/reperfusion injury
por: Chunchai, Titikorn, et al.
Publicado: (2022) -
Cell death inhibitors protect against brain damage caused by cardiac ischemia/reperfusion injury
por: Liao, Suchan, et al.
Publicado: (2021) -
Combined Vildagliptin and Metformin Exert Better Cardioprotection than Monotherapy against Ischemia-Reperfusion Injury in Obese-Insulin Resistant Rats
por: Apaijai, Nattayaporn, et al.
Publicado: (2014) -
PCSK9 inhibitor improves cardiac function and reduces infarct size in rats with ischaemia/reperfusion injury: Benefits beyond lipid‐lowering effects
por: Palee, Siripong, et al.
Publicado: (2019)